Onderneming Standard BioTools Inc.
Aandelen
LAB
US34385P1084
Geavanceerde medische apparatuur & technologie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,475 USD | -3,32% | -2,56% | +11,99% |
20/05 | Standard BioTools ontvangt aandeelhoudersvoorstel van Madryn Asset Management | CI |
08/05 | Transcript : Standard BioTools Inc., Q1 2024 Earnings Call, May 08, 2024 |
Vakgebied
Aantal werknemers: 537
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Consumables
39,3
%
| 47 | 47,8 % | 42 | 39,3 % | -10,80% |
Instruments
35,2
%
| 26 | 26,2 % | 37 | 35,2 % | +45,96% |
Service
24,4
%
| 24 | 24,2 % | 26 | 24,4 % | +9,56% |
Other
1,1
%
| - | - | 1 | 1,1 % | - |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
41,5
%
| 41 | 41,9 % | 44 | 41,5 % | +7,56% |
EMEA
34,0
%
| 33 | 33,8 % | 36 | 34,0 % | +9,25% |
China
14,9
%
| 11 | 11,5 % | 16 | 14,9 % | +39,82% |
Asia-Pacific
7,7
%
| 10 | 9,7 % | 8 | 7,7 % | -14,55% |
Americas
2,0
%
| 3 | 3,0 % | 2 | 2,0 % | -29,71% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michael Egholm
CEO | Chief Executive Officer | 61 | 04-04-22 |
Jeffrey Black
DFI | Director of Finance/CFO | 55 | 15-05-23 |
Shane Bowen
CTO | Chief Tech/Sci/R&D Officer | - | 05/01 |
Hanjoon Kim
COO | Chief Operating Officer | 53 | 04-04-22 |
Jeremy Davis
PRN | Corporate Officer/Principal | - | 12-06-22 |
Adam Taich
PRN | Corporate Officer/Principal | 49 | 05/01 |
Elizabeth Jensen
HRO | Human Resources Officer | 50 | 03-01-23 |
Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 70 | 01-04-22 | |
Fenel Eloi
BRD | Director/Board Member | 66 | 15-03-23 |
Kathy Hibbs
BRD | Director/Board Member | 60 | 05/01 |
Michael Egholm
CEO | Chief Executive Officer | 61 | 04-04-22 |
Eli Casdin
BRD | Director/Board Member | 51 | 04-04-22 |
Troy Cox
BRD | Director/Board Member | 60 | 05/01 |
Thomas Carey
CHM | Chairman | 62 | 05/01 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 377 171 511 | 365 761 625 ( 96,97 %) | 7 251 000 ( 1,922 %) | 96,97 % |
Bedrijfsgegevens
Standard BioTools, Inc.
2 Tower Place Suite 2000
94080, South San Francisco
+650 266 6000
http://www.standardbio.comSector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,99% | 917 mln. | |
+7,01% | 217 mld. | |
+11,01% | 190 mld. | |
+19,20% | 143 mld. | |
+30,79% | 111 mld. | |
+1,48% | 64,59 mld. | |
+13,95% | 52,36 mld. | |
-0,16% | 48,45 mld. | |
-6,20% | 38,03 mld. | |
+0,91% | 35,6 mld. |